Chemotherapy of Sporozoite- and Blood-Induced Plasmodium Berghei Infections with Selected Antimalarial Agents

Harry Most Department of Preventive Medicine, New York University School of Medicine, 550 First Avenue, New York, N.Y. 10016

Search for other papers by Harry Most in
Current site
Google Scholar
PubMed
Close
,
Robert Herman Department of Preventive Medicine, New York University School of Medicine, 550 First Avenue, New York, N.Y. 10016

Search for other papers by Robert Herman in
Current site
Google Scholar
PubMed
Close
, and
Cy Schoenfeld Department of Preventive Medicine, New York University School of Medicine, 550 First Avenue, New York, N.Y. 10016

Search for other papers by Cy Schoenfeld in
Current site
Google Scholar
PubMed
Close
Restricted access

Summary

On the basis of these preliminary observations, it appears that, provided suitable temperature-controlled insectaries are available, the A. stephensi-A/J mouse P. berghei cycle is a useful model for the evaluation of various applications of antimalarial agents including causal prophylaxis, suppressive, and curative therapy.

The short prepatent period must be considered together with the duration of persistence of the drug in blood or tissues in determining causal prophylaxis. An adequate dosage of sporozoites, which results in ready detection of exoerythrocytic stages in control and pretreated animals, is essential.

The response of sporozoite-induced infection with P. berghei to antimalarial drugs resembles in several ways that seen both in P. vivax and P. falciparum.

Author Notes

Past two years Past Year Past 30 Days
Abstract Views 798 189 20
Full Text Views 7 1 0
PDF Downloads 6 2 0
 

 

 

 
 
Affiliate Membership Banner
 
 
Research for Health Information Banner
 
 
CLOCKSS
 
 
 
Society Publishers Coalition Banner
Save